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eptifibatide was 3.83.3 hours. Femoral access was utilized in 60 patients (91%) with
closure devices in 39 (59%) and IABP used in 6 (9%). Three patients underwent index
admission CABG (2 elective, 1 urgent). There were 3 in-hospital deaths due to
cardiogenic shock (5%). There were no recurrent infarctions or stent thrombosis. There
was 1 AV fistula and 1 small retroperitoneal bleed not requiring surgery or transfusion.
Three patients received transfusion (2 post CABG, 1 GI bleed).
Univariate predictors of death/vascular complication/stent thrombosis/transfusion in-
clude: pre-lab arrest (p0.0006), IABP use (p0.014), transfer patient (p0.002) and
shock on admission (p0.03); the only independent predictor was pre-lab arrest (p0.03,
OR 11.1 (95% CI 1.2-129.6).
Conclusion: Abbreviated duration GPIIbIIIa may be a safe and novel alternate during
STEMI. Major bleeding post infarct PCI was low with no access site related transfusion
or surgery and no stent thrombosis.
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Background: Percutaneous coronary intervention (PCI) is superior to fibrinolytic
therapy (FT) in patients with ST elevation myocardial infarction (STEMI). However,
treatment delays in patients with STEMI presenting at rural hospitals that are transferred
for PCI may result in longer door to balloon time and lose the advantage of this approach
over FT.
Methods: We conducted a retrospective study of all patients presenting with STEMI
and undergoing PCI (primary, rescue and routine) at our center from January 2003
through May 2010. These patients were classified into two groups: Group 1 consisted of
patients presenting at rural hospitals that were transferred to our center for PCI and group
2 consisted of patients directly presenting to our center. The “total” door to balloon time
(TDBT) was calculated in minutes from the first documented time of initiation of
symptoms of the index event until the balloon inflation of the culprit artery. The primary
endpoint was major adverse cardiac events (MACE) which was a composite of one year
incidence of all cause mortality, recurrent acute coronary syndrome (RACS), and
cerebrovascular accident (CVA)/transient ischemic attack (TIA). Secondary endpoints
were individual components of MACE including all cause mortality, RACS, CVA/TIA
and in-hospital major bleeding. We conducted multivariate regression analysis to evaluate
the role of major demographic and clinical characteristics in predicting MACE.
Results: A total of 410 patients (278 in group 1 and 132 in group 2) qualified for the
study. There were no significant differences in the major demographic and clinical
characteristics between the two groups. TDBT was 177 75 minutes in group1 and 97
64 minutes in group 2 (p 0.01). Primary endpoint occurred in 20 % of patients in group
1 and 12 % of patients in group 2 (p 0.048). However, none of the secondary endpoints
were significantly different between the two groups. By multivariate regression analysis,
only rural transfer status and TDBT predicted MACE.
Conclusion: Rural Interhospital transfer of patients presenting with STEMI is associ-
ated with longer TDBT and higher incidence of MACE. Further research is needed to
realize the full benefit of PCI in these patients.
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Background: After Primary Angioplasty in acute myocardial infarction (PAAMI), the
TIMI of myocardial perfusion grade (TMPG) “myocardial blush”, is a useful but
subjective method of microcirculation analysis, with prognostic implications. On the other
hand, the addition of complete ST segment resolution (CSTR)70% is a hard and
more objective marker, providing information about tissue level perfusion. We analyzed if
exist correlation between TMPG and CSTR in patients with normal epicardial flow
TIMI 3.
Material and Methods: From January 2007 to September 2012, we analyzed
retrospectively the ECG (at admission and after 30 minutes from angioplasty) and the
TMPG from 406 patients (4 centers from Argentina), with PAAMI12hs, all these
patients with normal epicardial flow TIMI 3.The admission Killip and Kimbal was A
86%, B11% and D3%. We evaluated the microcirculation grades like TMPG 3
normal entry and exit of dye from the microvasculature, TMPG 2 delayed entry and exit
of dye from the microvasculature, TMPG 1 Dye slowly enters but fails to exit the
microvasculature and TMPG 0 failure of dye to enter the microvasculature. We defined:
opened microcirculation if TMPG was 2/3 and closed if TMPG was 0/1 at the final result
of PAAMI. We considered CSTR, like70% reduction of ecg after angioplasty, from
the initial value at admission. We had 84 patients with mechanical Thrombus Aspiration,
40 cases in TMPG0/1 group and 44 in TMPG2/3.
Results: 280/406 patients (68,9%) had CSTR at 30 minutes. Complete CSTR was
more significative in patients with opened TMPG 2/3 (240/302, 79,47%) than patients
with closed TMPG 0/1 (40/104, 38,4%), in spite of normal coronary epicardial flow;
P0.0004.
Conclusion: Exist direct correlation between CSTR and opened TMPG 2/3. Both
methods were useful in the analysis of microcirculation.
Timi Flow and ST segment after PAAMI, using Fisher’s test. P0.0004
n406 (TMPG2/3) 302 (TMPG0/1) 104
(CSTR) 280 240 (79,47%) 40 (38,4%)
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Background: After Primary Angioplasty in acute myocardial infarction (PAAMI), the
TIMI of myocardial perfusion grade (TMPG) “myocardial blush”, is a useful method of
microcirculation analysis, with prognostic implications. On the other hand, the presence
of angiographic thrombus (AT) generates distal embolism, affecting the microcirculation.
We analyzed if AT can predict bad myocardial blush after the angioplasty.
Material and Methods: From January 2007 to September 2012 we studied retrospec-
tively coronary angiograms and the TMPG of 406 patients from 4 centers of Argentina,
with PAAMI12 hours, all these patients with TIMI 3 after angioplasty. The average
age was 5814 years old. The admission Killip and Kimbal was A 86%, B11% and
D3%. We evaluated the microcirculation grades like TMPG 3 normal entry and exit of
dye from the microvasculature, TMPG 2 delayed entry and exit of dye from the
microvasculature, TMPG 1 Dye slowly enters but fails to exit the microvasculature and
TMPG 0 failure of dye to enter the microvasculature. We considered (opened circulation)
if TMPG was 2/3 and closed if TMPG was 0/1, at the final result of PAAMI. We
defined AT like intraluminal globular filling defect in multiple angiographic views. We
had 84 patients with mechanical thrombus aspiration, 40 cases in TMPG0/1 group and
44 in TMPG2/3.
Results: The incidence of AT before PAAMI was 360/406 patients (88,66%). 98/104
patients had AT before Angioplasty  TMPG 0/1 after PAAMI (94,23%) Vs 262/302
patients with AT  TMPG 2/3, (86,75%); P0,62.
Conclusions: The presence of angiographic thrombus didn=t predict bad TIMI Flow,
obtaining a trivial trend toward more incidence of closed microcirculation.
$$MISSING OR BAD TABLE SPECIFICATION {01F24CA0-4CB4-45BC-
9F4B-9D46051CAC25}$$
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AT and Timi Flow after PAAMI, using Fisher’s Test. P0,62
n406 (AT) 360 %
(TMPG0/1) 104 98 94,2
(TMPG2/3) 302 262 86,7
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Background: It is well known that hyperglycemia and elevated HbA1c level on admission
are poor prognostic factors in diabetic patients with acute myocardial infarction (AMI). but the
use of intensive therapy to target normal HbA1c level increased mortality and did not
significantly reduce major cardiovascular events in ACCORD Study. is the less than 6.0%
HbA1c level on admission safe in diabetic patients with AMI? The aim of this study was to
determine the contribution of HbA1c at admission on prognosis of AMI.
Methods: A total of 2,679 diabetic patients with AMI in KorMI registry between
January 2008 and August 2011. There are 1,360 ST segment elevation myocardial
infarction and 1319 non ST segment elevation myocardial infarction. Plasma HbA1c
levels were available for all patients. We categorized the patients according to HbA1c
level, Group I 6%, Group II 6. 1-month and 12-month major adverse cardiac event
(MACE) was defined as either all cause of death, myocardial infarction and any type of
revascularization.
Results: Less than 6.0% HbA1c Group I had a higher 1-month and 12-month MACE
than over the 6.0% HbA1c Group II. In multiple logistic regression analysis, less than
6.0% HbA1c was related to an increased risk of developing MACE (odds ratio 2.80, 95%
confidence interval 1.63-4.80, p0.001).
Conclusion: Less than 6.0% HbA1c on admission might be an important poor
prognostic factor in diabetic patients with AMI at 1-month and 12-month follow-up.
HbA1c<6.0% HbA1c>6.0%
Patient Number 201 2478
1 month MACE 29 (14.4%) 205 (8.3%) p0.01
12 month MACE 43 (21.4%) 322 (13.0%) p0.001
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Purpose: There is no evidence to apply a differentiated approach to the choice of
revascularization strategy for patients with ST-elevation myocardial infarction (STEMI)
and multivessel disease (MVD). Thirty-day and long-term outcomes of different strate-
gies of revascularization in a cohort of STEMI patients with MVD, depending on the
severity of coronary stenosis on a SYNTAX SCORE were analyzed.
Methods: Outcomes of different revascularization strategies in 227 STEMI patients in
the aspect of an objective assessment of the severity of coronary lesions on a SYNTAX
SCORE were studied. The first group consisted of patients who underwent multivessel
stenting (MS) strategy in the primary PCI (n  40), the second group consisted of
patients defined by staged revascularization (SR) (n 187). Each group was divided into
subgroups according to severity of coronary lesions on a SYNTAX SCORE: SYNTAX
 22 (moderate) and SYNTAX  23 (severe).
Results: Subgroups of patients with SYNTAX  23, as a group, MS, and SR group at
baseline were associated with decreased left ventricular ejection fraction compared with
subgroups SYNTAX  22 (p 0.05). In the SR group,as for 30 days and within 12
months observation was significantly more frequent need for non-target vessel
revascularization(non-TVR) compared with the group of MS, 13.3% vs 0, and 50.3% vs
15%, respectively (p 0.05). In 12 months observation SR group had combined
end-point (death  myocardial infarction  target vessel revascularization (TVR)) 23%
vs. 7.5% in the MS group (p 0.05). SYNTAX  23 in the SR group compared with
SYNTAX»  22 was associated with significantly greater frequency of death, 11.5% vs.
2.75% (p0.05) and combined end-point, 29.5% vs. 18.3% (p0.05), respectively for 12
months observation.
Conclusion: In a cohort of STEMI patients with MVD revealed the relationship
between severe coronary stenosis (SYNTAX  23) and a number of clinical and
angiographic parameters, in particular, is reflected in the frequency of adverse outcomes at
12 months of observation. The strategy of MS had satisfactory results at 12 months of
observation regardless of the severity of coronary lesions, whereas patients with SR group
(SYNTAX 23) showed worse outcomes compared with patients with moderate severity
of coronary lesions (SYNTAX  22).
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Objective: The aim of this study is to compare the efficacy and safety of prasugrel 60 mg
vs. clopidogrel 600 mg loading doses in patients undergoing primary PCI for acute
STEMI.
Background: There is ever increasing evidence to suggest that potent antiplatelet therapy
plays a crucial role in the management of patients with Acute Coronary syndromes
(ACS). Recent randomized trial demonstrated greater reduction in infarct size with
clopidogrel 600 mg vs. 300 mg loading doses in patients undergoing primary PCI for
STEMI. While the Triton TIMI 38 trial demonstrated superiority of prasugrel 60 mg to
clopidogrel 300 mg load in patients with ACS, to our knowledge there has never been a
head to head comparison between prasugrel 60 mg vs. clopidogrel 600 mg loading doses.
Methods: This was a retrospective observational study comparing patients presenting
with acute STEMI, who were treated with prasugrel 60 mg vs. clopidogrel 600 mg
loading doses. These were sequential patients based on a protocol driven change from
clopidogrel to prasugrel. The primary end point was the evaluation of infarct size, based
on peak CK and CK-MB elevation. Secondary end points include global discharge LVEF
and TIMI flow grade before and after PCI. Safety endpoint was in-hospital bleeding
complications.
Results: Mean age of the study subjects was 56 years, with 82% being males. There was no
statistically significant difference between the two groups in terms of infarct size. The peak CK
was 1442 1128 U/L in the prasugrel group (n38) vs. 1522 1467 U/L in the clopidogrel
group (n34) (p0.79). The peak CK-MB was 132 100 ng/ml in the prasugrel group vs.
123 117 ng/ml in the clopidogrel group (p0.73). Similarly, there were no significant
differences in the prespecified secondary end points and safety end point.
Conclusions: In patients undergoing primary PCI for acute STEMI, pretreatment with
prasugrel 60 mg vs. clopidogrel 600 mg was not associated with significant difference in
infarct size. These findings support the need for additional randomized trials to determine
the relative efficacy of these two different strategies in the acute STEMI population.
CRT-21
Role Of Intracoronary Injection Of Na-nitroprusside In Preventing No-reflow
Phenomenon In Patients With STEMI During Primary Percutaneous Coronary
Intervention
Ahmed ElMahmoudy Nayel,1 Aly Ahmed Elabd,1 Hytham Fathalla2
1Ain-Shams university, Cairo, Egypt 2National heart institute, Cairo, Egypt
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S , V O L . 6 , N O . 2 , S u p p l S , 2 0 1 3 S7
C
O
R
O
N
A
R
Y
